Developer docs
API playgroundTry for free, no card

Search company profiles

Asembia

Full company profile

uuid0007q7n

Namestring
Asembia
Legal namestring
Asembia LLC
Websiteurl
asembia.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Asembia is a privately held specialty pharmaceutical services company founded in 2005 and headquartered in Florham Park, New Jersey, operating as a platform-based ecosystem serving pharmaceutical manufacturers, biotech companies, specialty pharmacies, health systems, prescribers, and payors across the USA. The company pioneered specialty pharmacy as a distinct class of trade and built a leading group purchasing organization (GPO) focused on this segment.

Its core technology is Asembia-1, an integrated web-based software platform that optimizes operations, workflow, and patient management while delivering business intelligence. Around this platform Asembia offers modular products including Prescriber Portals (referral and prescription status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking and reporting), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. ASPN Pharmacies, a wholly owned subsidiary division, obtained Surescripts RxTransfer certification in December 2025 to enable secure electronic prescription transfers.

Asembia's revenue model blends managed services (Patient Access + Connected Care, Distribution Strategy, Pharmacy Network), transaction-based GPO fees (group purchasing discounts, rebates, and incentive programs), and subscription/recurring revenue from technology and Data + Business Insights offerings. The company contracts with 35,000+ pharmacies in the USA, employs over 800 professionals, and operates the AXS annual summit, which at AXS26 drew nearly 10,000 attendees from 1,500+ organizations. Recent strategic moves include a partnership with Outcomes (April 2025) extending reach to 100+ million lives and the launch of the ASPN Digital Retail Network (April 2026).

Short descriptiontext

Asembia is a privately held specialty pharmaceutical services company that provides patient access, distribution strategy, group purchasing, pharmacy network, data insights, and technology solutions to pharmaceutical manufacturers, specialty pharmacies, health systems, and prescribers across the USA.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersFlorham Park, United States
HQ citystring
Florham Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy services, pharmaceutical distribution, group purchasing organization, patient access services, pharmacy network management
Industry2 codes
1Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP)
CodeHLACAKAOPrimaryYes
2Specialty Pharma & Biologics Distribution (GDP-compliant)
CodeHLAGAMADPrimaryNo
NAICS code1 code
  • All Other Miscellaneous Ambulatory Health Care Services621999
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Specialty Pharmacy Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Patient Access + Connected Care Services
TypeManaged Services
Description

Customizable and scalable patient support service model streamlining intake, benefit investigation, prior authorization, and other patient access activities through patient support centers. Includes clinical expertise, compassionate care coordinators, and compliance/adherence programs.

asembia.com
2Group Purchasing Organization (GPO)
TypeTransaction Fee
Description

Negotiates discounts with distributors and vendors, finds rebates, fee-to-service programs, and creates incentive opportunities for pharmaceutical manufacturers, distributors, vendors, and suppliers. Provides product cost savings through longstanding relationships.

asembia.com
3Distribution Strategy Services
TypeManaged Services
Description

Expert advisory services for distribution channel optimization, including identifying redundancies, waste elimination, new growth areas, and cost savings through distribution channels. Tailored network development for partners.

asembia.com
4Pharmacy Network Services
TypeManaged Services
Description

Contracts, aligns, supports, and services products across 35,000+ pharmacies in the USA. Includes network optimization, pharmacy network development, and fulfillment services across retail, specialty, health system, and home delivery channels.

asembia.com
5Data + Business Insights
TypeSubscription Recurring
Description

Multi-channel data intelligence services providing real-time insights across retail, specialty, home delivery, infusion, health systems, long-term care, and payor channels. Includes data analytics, trend monitoring, and actionable insights.

asembia.com
6Technology + Software Solutions
TypeSubscription Recurring
Description

Proprietary technology platforms including Asembia-1, prescriber portals, PA solutions, manufacturer dashboards, and pharmacy analytics sold as integrated software solutions.

asembia.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Asembia-1
Description

An integrated, web-based software platform that optimizes operations, workflow, and patient management while providing robust business intelligence.

asembia.com
+1 more record
Core offering1 text field

Asembia provides specialty pharmaceutical services to pharmaceutical manufacturers, biotech companies, pharmacies, and healthcare providers through an integrated ecosystem encompassing Patient Access and Connected Care (HUB services), Distribution Strategy advisory, Group Purchasing Organization services, a 35,000+ pharmacy network, multi-channel Data and Business Insights, and the proprietary Asembia-1 technology platform. The company streamlines specialty medication access, prior authorization, patient adherence, and distribution for complex therapies across the US market.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Pharmacy professionals view expanding role of pharmacists as leading growth opportunity (77% in XiFin survey)
+2 more records
Product overview1 text field

Asembia is a specialty pharmaceutical services company that operates as a platform-based ecosystem. The core technology is the Asembia-1 integrated web-based software platform, which serves as the central hub supporting operations, workflow, patient management, and business intelligence. Around this platform, Asembia offers multiple software modules including Prescriber Portals (streamlined referrals and Rx status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. The company complements its technology with service offerings: Patient Access + Connected Care (patient support and education programs with pharmacy distribution), Distribution Strategy (advisory and execution services), Group Purchasing (GPO with negotiated discounts), Pharmacy Network (35,000+ contracted pharmacies), and Multi-Channel Intelligence/Data Analytics services. Founded in 2005, Asembia pioneered specialty pharmacy as a distinct class of trade and developed the leading GPO for this segment.

Product and service1 record
1Asembia-1
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-03
Description

ASPN Pharmacies, a division of Asembia LLC, obtained Surescripts RxTransfer certification. This certification enhances interoperability, reduces prescription errors, and accelerates care transitions by enabling secure electronic prescription transfers between pharmacies. The certification supports pharmacists and retail pharmacy partners in streamlining prescription management and improving patient access to therapies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-17
Description

Strategic partnership integrating Asembia's HUB services into Outcomes' clinical engagement platform. This collaboration enables proactive patient engagement during the prescription journey, allowing patients to directly reach out to Asembia's patient services team for timely assistance with prescribed therapies. The Outcomes platform connects with over 100 million lives through its network of pharmacies. The partnership aims to reduce prescription abandonment and improve health outcomes.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Top-3 US pharmaceutical distributor with significant specialty distribution, GPO, and biopharma services — broad incumbent competing across multiple of Asembia's product lines including distribution strategy and data services.

TypeBroad incumbent
Description

Largest US pharma distributor with US Oncology, Biologics-by-McKesson, and CoverMyMeds prior-authorization platform — competes in specialty distribution, patient access, and PA technology where Asembia also operates.

TypeDirect peer
Description

Eversana is a privately-held life sciences commercialization services provider offering patient services, distribution, GPO-style support, and data/analytics to pharma manufacturers — closely mirroring Asembia's integrated service stack for specialty pharma.

TypeDirect peer
Description

Specialty pharmacy provider embedded in health systems, partnering with Asembia (per Asembia customer data) on pharmacist-led specialty care models that improve outcomes — comparable specialty-pharmacy-network + patient-services orientation.

TypeDirect peer
Description

Specialty and rare-disease pharmacy with strong manufacturer and patient support services focus; competes with Asembia's pharmacy network and patient access services in the high-touch specialty and rare disease segments.

TypeDirect peer
Description

Specialty pharma services firm providing commercialization, market access, patient services, and data analytics to biopharma — overlaps with Asembia's Patient Access, Distribution Strategy, and Data + Business Insights offerings.

TypeBroad incumbent
Description

Largest US PBM with integrated specialty pharmacy (Accredo) and patient services — competes with Asembia's HUB, distribution strategy, and patient access offerings within the specialty value chain.

TypeBroad incumbent
Description

Large retail pharmacy chain with a significant specialty pharmacy arm (AllianceRx Walgreens Prime) — overlaps with Asembia's pharmacy network and specialty distribution services.

TypeBroad incumbent
Description

Vertically integrated PBM-pharmacy-insurer that operates CVS Specialty and Aetna; both a customer/partner of Asembia at industry summits and a direct competitor across specialty pharmacy, PA, and patient engagement.

TypeBroad incumbent
Description

Major US pharma distributor and specialty services provider (via its US Bioservices/Lash Group) — competes across specialty distribution, HUB services, and patient access where Asembia operates.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Asembia

Specialty Pharmacy Servicesasembia.com

Asembia is a privately held specialty pharmaceutical services company that provides patient access, distribution strategy, group purchasing, pharmacy network, data insights, and technology solutions to pharmaceutical manufacturers, specialty pharmacies, health systems, and prescribers across the USA.

What Asembia does

Asembia is a privately held specialty pharmaceutical services company founded in 2005 and headquartered in Florham Park, New Jersey, operating as a platform-based ecosystem serving pharmaceutical manufacturers, biotech companies, specialty pharmacies, health systems, prescribers, and payors across the USA. The company pioneered specialty pharmacy as a distinct class of trade and built a leading group purchasing organization (GPO) focused on this segment.

Its core technology is Asembia-1, an integrated web-based software platform that optimizes operations, workflow, and patient management while delivering business intelligence. Around this platform Asembia offers modular products including Prescriber Portals (referral and prescription status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking and reporting), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. ASPN Pharmacies, a wholly owned subsidiary division, obtained Surescripts RxTransfer certification in December 2025 to enable secure electronic prescription transfers.

Asembia's revenue model blends managed services (Patient Access + Connected Care, Distribution Strategy, Pharmacy Network), transaction-based GPO fees (group purchasing discounts, rebates, and incentive programs), and subscription/recurring revenue from technology and Data + Business Insights offerings. The company contracts with 35,000+ pharmacies in the USA, employs over 800 professionals, and operates the AXS annual summit, which at AXS26 drew nearly 10,000 attendees from 1,500+ organizations. Recent strategic moves include a partnership with Outcomes (April 2025) extending reach to 100+ million lives and the launch of the ASPN Digital Retail Network (April 2026).

Asembia firmographics

Firmographics
Name
Asembia
Legal name
Asembia LLC
Website
https://asembia.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Asembia is a privately held specialty pharmaceutical services company that provides patient access, distribution strategy, group purchasing, pharmacy network, data insights, and technology solutions to pharmaceutical manufacturers, specialty pharmacies, health systems, and prescribers across the USA.
Ownership category
akta.pro rank

Asembia industry classification

Industry
Product category
Specialty Pharmacy Services
NAICS
All Other Miscellaneous Ambulatory Health Care Services (621999)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO)
akta.pro secondary industry
Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

  • Specialty pharmacy services
  • Pharmaceutical distribution
  • Group purchasing organization
  • Patient access services
  • Pharmacy network management

Where Asembia is headquartered

Location

Headquarters

HQ city
Florham Park
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Asembia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

  1. Patient Access + Connected Care Services: Customizable and scalable patient support service model streamlining intake, benefit investigation, prior authorization, and other patient access activities through patient support centers. Includes clinical expertise, compassionate care coordinators, and compliance/adherence programs.
  2. Group Purchasing Organization (GPO): Negotiates discounts with distributors and vendors, finds rebates, fee-to-service programs, and creates incentive opportunities for pharmaceutical manufacturers, distributors, vendors, and suppliers. Provides product cost savings through longstanding relationships.
  3. Distribution Strategy Services: Expert advisory services for distribution channel optimization, including identifying redundancies, waste elimination, new growth areas, and cost savings through distribution channels. Tailored network development for partners.
  4. Pharmacy Network Services: Contracts, aligns, supports, and services products across 35,000+ pharmacies in the USA. Includes network optimization, pharmacy network development, and fulfillment services across retail, specialty, health system, and home delivery channels.
  5. Data + Business Insights: Multi-channel data intelligence services providing real-time insights across retail, specialty, home delivery, infusion, health systems, long-term care, and payor channels. Includes data analytics, trend monitoring, and actionable insights.
  6. Technology + Software Solutions: Proprietary technology platforms including Asembia-1, prescriber portals, PA solutions, manufacturer dashboards, and pharmacy analytics sold as integrated software solutions.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Asembia product offering

Product offering

Core offering

Asembia provides specialty pharmaceutical services to pharmaceutical manufacturers, biotech companies, pharmacies, and healthcare providers through an integrated ecosystem encompassing Patient Access and Connected Care (HUB services), Distribution Strategy advisory, Group Purchasing Organization services, a 35,000+ pharmacy network, multi-channel Data and Business Insights, and the proprietary Asembia-1 technology platform. The company streamlines specialty medication access, prior authorization, patient adherence, and distribution for complex therapies across the US market.

Product overview

Asembia is a specialty pharmaceutical services company that operates as a platform-based ecosystem. The core technology is the Asembia-1 integrated web-based software platform, which serves as the central hub supporting operations, workflow, patient management, and business intelligence. Around this platform, Asembia offers multiple software modules including Prescriber Portals (streamlined referrals and Rx status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. The company complements its technology with service offerings: Patient Access + Connected Care (patient support and education programs with pharmacy distribution), Distribution Strategy (advisory and execution services), Group Purchasing (GPO with negotiated discounts), Pharmacy Network (35,000+ contracted pharmacies), and Multi-Channel Intelligence/Data Analytics services. Founded in 2005, Asembia pioneered specialty pharmacy as a distinct class of trade and developed the leading GPO for this segment.

Differentiator

Problem solved

Functional benefit

Brands

  • Asembia-1: An integrated, web-based software platform that optimizes operations, workflow, and patient management while providing robust business intelligence.
  • ASPN Digital Retail Network

Products and services

  • Asembia-1

Quantifiable outcome

  • Pharmacy professionals view expanding role of pharmacists as leading growth opportunity (77% in XiFin survey)
  • +2 more outcomes

Companies that use Asembia

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Asembia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Asembia partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • SurescriptscoreTechnology or Integration · 3 December 2025ASPN Pharmacies, a division of Asembia LLC, obtained Surescripts RxTransfer certification. This certification enhances interoperability, reduces prescription errors, and accelerates care transitions by enabling secure electronic prescription transfers between pharmacies. The certification supports pharmacists and retail pharmacy partners in streamlining prescription management and improving patient access to therapies.
  • OutcomescoreStrategic or Co-development Partner · 17 April 2025Strategic partnership integrating Asembia's HUB services into Outcomes' clinical engagement platform. This collaboration enables proactive patient engagement during the prescription journey, allowing patients to directly reach out to Asembia's patient services team for timely assistance with prescribed therapies. The Outcomes platform connects with over 100 million lives through its network of pharmacies. The partnership aims to reduce prescription abandonment and improve health outcomes.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Asembia competitors and assessment

Company assessment

Broad incumbents

  • Cardinal Health: Top-3 US pharmaceutical distributor with significant specialty distribution, GPO, and biopharma services — broad incumbent competing across multiple of Asembia's product lines including distribution strategy and data services.
  • McKesson: Largest US pharma distributor with US Oncology, Biologics-by-McKesson, and CoverMyMeds prior-authorization platform — competes in specialty distribution, patient access, and PA technology where Asembia also operates.
  • Express Scripts / Evernorth (Cigna): Largest US PBM with integrated specialty pharmacy (Accredo) and patient services — competes with Asembia's HUB, distribution strategy, and patient access offerings within the specialty value chain.
  • Walgreens Boots Alliance (AllianceRx Walgreens Prime): Large retail pharmacy chain with a significant specialty pharmacy arm (AllianceRx Walgreens Prime) — overlaps with Asembia's pharmacy network and specialty distribution services.
  • CVS Health (CVS Specialty / Caremark): Vertically integrated PBM-pharmacy-insurer that operates CVS Specialty and Aetna; both a customer/partner of Asembia at industry summits and a direct competitor across specialty pharmacy, PA, and patient engagement.
  • Cencora (formerly AmerisourceBergen): Major US pharma distributor and specialty services provider (via its US Bioservices/Lash Group) — competes across specialty distribution, HUB services, and patient access where Asembia operates.

Direct peers

  • Eversana: Eversana is a privately-held life sciences commercialization services provider offering patient services, distribution, GPO-style support, and data/analytics to pharma manufacturers — closely mirroring Asembia's integrated service stack for specialty pharma.
  • Shields Health Solutions: Specialty pharmacy provider embedded in health systems, partnering with Asembia (per Asembia customer data) on pharmacist-led specialty care models that improve outcomes — comparable specialty-pharmacy-network + patient-services orientation.
  • PANTHERx Rare Pharmacy: Specialty and rare-disease pharmacy with strong manufacturer and patient support services focus; competes with Asembia's pharmacy network and patient access services in the high-touch specialty and rare disease segments.
  • Precision Medicine Group: Specialty pharma services firm providing commercialization, market access, patient services, and data analytics to biopharma — overlaps with Asembia's Patient Access, Distribution Strategy, and Data + Business Insights offerings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

Asembia social profiles

Digital presence

Asembia compliance and trust

Trust signal

Compliance2 records

Asembia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Asembia leadership team

Management profile

Number of profiles

Profiles3 records

Asembia subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Asembia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Asembia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asembia

What does Asembia do?

Asembia provides specialty pharmaceutical services to pharmaceutical manufacturers, biotech companies, pharmacies, and healthcare providers through an integrated ecosystem encompassing Patient Access and Connected Care (HUB services), Distribution Strategy advisory, Group Purchasing Organization services, a 35,000+ pharmacy network, multi-channel Data and Business Insights, and the proprietary Asembia-1 technology platform. The company streamlines specialty medication access, prior authorization, patient adherence, and distribution for complex therapies across the US market.

Is Asembia a public or private company?

Asembia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Asembia founded?

Asembia was founded in 2005. It employs 501 to 1,000 people.

Where is Asembia based?

Asembia is headquartered in Florham Park, United States, in the North America region.

How does Asembia make money?

Six revenue lines are on record. Patient Access + Connected Care Services are the primary driver. The others are group Purchasing Organization (GPO), distribution Strategy Services, pharmacy Network Services, data + Business Insights and technology + Software Solutions.

Who are Asembia's main competitors?

Broad incumbents on record are Cardinal Health, McKesson, Express Scripts / Evernorth (Cigna), Walgreens Boots Alliance (AllianceRx Walgreens Prime), CVS Health (CVS Specialty / Caremark) and Cencora (formerly AmerisourceBergen). Direct peers are Eversana, Shields Health Solutions, PANTHERx Rare Pharmacy and Precision Medicine Group.

Does Asembia have an API?

No public API is recorded for Asembia.

What industry is Asembia in?

Asembia's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAO, Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP), with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 621999 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesSpecialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia BuyCigna Group's Evernorth health services business has committed $100 million through 2028 to launch an AI-powered specialty pharmacy program called 'Pharmacy Forward,' enabling care teams to reduce prescription processing timelines and improve patient outcomes. Private equity firm Peak Rock Capital simultaneously acquired Asembia, a specialty pharmacy services provider covering distribution, group purchasing, and patient-facing technology, though financial terms were not disclosed. These transactions are part of a broader wave of investment in specialty pharmacy as health insurers including Cigna, Humana, Elevance Health, and UnitedHealth Group compete for a share of the fast-growing sector, where specialty drugs account for more than half of total prescription spending.Pulse 2.0Peak Rock Capital Acquires AsembiaAn affiliate of Peak Rock Capital has completed the acquisition of Asembia, a provider of end-to-end technology-enabled commercialization solutions for the specialty pharmaceutical industry headquartered in Florham Park, New Jersey. Financial terms of the transaction were not disclosed. Peak Rock Capital, a private investment firm focused on the middle market, plans to partner with the Irene family and Asembia's management to invest in technology, capabilities, and growth initiatives, while pursuing complementary acquisitions to support accelerated growth.ForbesPeak Rock Capital Buys Asembia As Specialty Pharmacy Industry GrowsPrivate equity firm Peak Rock Capital has acquired Asembia, a specialty pharmacy services provider founded in 2004 that offers distribution, group purchasing, and technology connecting patients, drug makers, prescribers, and pharmacies. Financial terms were not disclosed, but Peak Rock Capital typically invests in the range of $50 million to $1.5 billion. Asembia CEO Lawrence Irene stated the investment will fund growth, technology, and innovation, with specialty drugs now accounting for over 60% of employer drug spending, particularly GLP-1 medicines for obesity.PR NewswirePEAK ROCK CAPITAL AFFILIATE COMPLETES ACQUISITION OF ASEMBIAAn affiliate of Peak Rock Capital has completed the acquisition of Asembia LLC, a specialty pharma services company headquartered in Florham Park, New Jersey. Asembia provides end-to-end technology-enabled commercialization solutions to the specialty pharma industry, including patient support HUB services, specialty distribution, data services, pharmacy software, and group purchasing solutions, and it operates the largest national specialty pharmacy conference. The transaction reflects Peak Rock's strategy of investing in founder-owned healthcare businesses, with BofA Securities serving as exclusive financial advisor to Asembia and Houlihan Lokey advising Peak Rock.Venture Capital Access OnlinePEAK ROCK CAPITAL AFFILIATE COMPLETES ACQUISITION OF ASEMBIAA Peak Rock Capital affiliate completed the acquisition of Asembia, a specialty pharma commercialization provider. The deal includes investments in technology, marketing, and growth initiatives, with plans for complementary acquisitions to support accelerated growth.PR NewswireAsembia's AXS26 Summit Showcases the Future of Specialty Pharmacy & Patient AccessAsembia's AXS26 Summit drew nearly 10,000 attendees from more than 1,500 organizations to the Wynn & Encore Las Vegas from April 26–30, 2026, cementing its position as a leading industry conference for specialty pharmacy stakeholders. CVS Health announced its new \u0022Health 100\u0022 business unit, developed in partnership with Google Cloud's AI technology, aimed at increasing consumer engagement and improving health outcomes. Lisa Gill of JPMorgan noted that rising healthcare costs stem primarily from non-pharmacy sectors, while Luke Greenwalt of IQVIA highlighted that over 20% of branded drug net sales face exclusivity loss risk amid an average $2.2 billion R&D cost per drug.MorningstarAsembia's AXS26 Summit Showcases the Future of Specialty Pharmacy & Patient AccessAsembia's AXS26 Summit drew nearly 10,000 attendees from more than 1,500 organizations to Wynn & Encore Las Vegas from April 26–30, 2026, cementing its position as a leading industry gathering for specialty pharmacy stakeholders. Industry speakers including representatives from IQVIA, JPMorgan, CVS Health, Walgreens, and Google Cloud discussed topics spanning value-based care payment models, AI integration in patient engagement, and the financial pressures facing pharmaceutical manufacturers. Planning is already underway for the 2027 summit at the same venue.Managed Healthcare ExecutiveExpanding specialty pharmacy services could help health systems improve outcomes and manage chronic disease costsAt the Asembia Specialty Pharmacy Summit in Las Vegas on April 27, presenters from UMass Memorial Health and Shields Health Solutions shared findings from a UMass specialty pharmacy program showing that pharmacist-led models expanding into care management services can improve chronic disease outcomes and reduce hospital admissions. The program combines lifestyle counseling, social determinants support, and mental health referrals with value-based care arrangements to generate shared savings, and speakers argued this approach can be applied across multiple chronic conditions beyond diabetes.PR NewswireHealthWell Foundation to Moderate Panel and Exhibit at Asembia's AXS26 SummitThe HealthWell Foundation announced its participation at Asembia's AXS26 Summit scheduled for April 26-30, 2026, in Las Vegas, Nevada. HealthWell President and CEO Michael Heimall will moderate a panel discussion on the role of specialty pharmacies in charitable patient assistance programs, focusing on best practices for patient enrollment and addressing concerns about alternative funding programs.PR NewswireAsembia Announces Charlie Sheen as General Session Speaker for the 2026 Annual Specialty Pharmacy SummitAsembia announced that actor Charlie Sheen will serve as a general session speaker at its 2026 Specialty Pharmacy Summit, scheduled for April 26-30, 2026 at the Wynn and Encore in Las Vegas. Sheen will participate in a fireside discussion focused on themes of resilience, reinvention, and personal transformation relevant to the healthcare community. The announcement frames Sheen's public struggles and recovery as aligning with the healthcare sector's mission to support people at vulnerable moments.